The pharmaceutical company has announced encouraging results from a clinical trial focused on virus-fighting antibodies.
The human immune system can't beat back a pathogen if its many players don’t hit the right notes at the right times. A new study finds that people who suffer the most from COVID-19 have an immune response that’s out of sync.
Since the coronavirus pandemic began, Turkish authorities have used judicial harassment and administrative investigations to silence public health officials who try to speak out.
When Azmera Shaikh's family was in quarantine, the rules made it difficult to put out garbage and get groceries. Yet neighbors did not help. Their attitude, she says, was “more traumatizing than the illness itself.”
Do people who suffered a mild or moderate bout of COVID-19 months ago need to worry about their heart health? Scientists search for the answer.
Prisoners have been excluded from vaccine trials out of concern that they may be coerced into participating, but researchers say that including the vulnerable population in COVID-19 studies could have outsize health benefits.
Permitting for controlled burns across the country has been suspended during the coronavirus pandemic, in part because smoke inhalation may heighten one's risk of infection.
Epidemiologist Caitlin Rivers urged the government to develop a plan to eliminate test shortages and anticipate bottlenecks in supplies. Things may have gone differently if more officials had listened to her.
Dozens of studies have reported that many of the sickest COVID-19 patients have been people with obesity, as a constellation of physiological and social factors drive those grim numbers.
Although fecal transmission of a pathogen is tricky to confirm—and proving that a virus spreads via building waste pipes is even more difficult—it is entirely possible, several researchers tell ScienceInsider.
What do you think about staging a Manhattan Project to make a COVID-19 vaccine? Moncef Slaoui was asked in early May. He now addresses fears that the upcoming elections might influence the vaccine approval process.
"We’re at risk of gambling away our success,” virologist Christian Drosten warned in the German newspaper Die Zeit. His message referred to Germany, but it could have been addressed to all of Europe.